Ondansetron
Product Images NDC 11819-371

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 11819-371). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by United States Department Of Health & Human Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Single Dose Package (11819 371 01 Label 1)

Single Dose Package (11819 371 01 Label 1)
ONDANSETRON Orally Disintegrating Tablets manufactured by Mylan Pharmaceuticals Inc are used to treat nausea and vomiting caused by chemotherapy or radiation treatment. Each blister contains one tablet with a strength of 8mg. These tablets are designed to dissolve when placed on the tongue without the need for water. They should be stored at controlled room temperature and should not be pushed through the blister packaging. The lot number provided is 0000000.*
FDA Label Image

Package Of 5 (11819 371 28 Label 1)

Package Of 5 (11819 371 28 Label 1)
NDC: 11819-371-28 and NSN: 6505-00-000-0037 are identification numbers for Ondansetron, Orally Disintegrating Tablets, USP 8mg available in 5 packs. The product is packaged by HHS Supply Service Center, located in Perry Point, MD 21902, and manufactured by Mylan Pharmaceuticals Inc. The product should be stored at a controlled room temperature between 25°C-120° (68°F-77°F). The available lot number is 00000, and the expiry date is 00/0000.*
FDA Label Image

Ondansetron Structural Formula (Image 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.